Increased levels of YY1 are correlated with poor survival prognosis in patients with diffuse large B-cell lymphoma (DLBCL) [83,84], high-grade DLBCL, or Burkitt’s lymphoma [85], suggesting an oncogenic function of YY1 in human B-cell lymphoma genesis [86]. The gene discussed is YY1; the disease is B-cell non-Hodgkin lymphoma.